Clinical studies have demonstrated that increased level of inflammatory parameters related to acute phase reaction such as interleukin-6 or C-reactive protein (CRP) predicts unfavorable outcome in ischemic stroke patients (reviewed in [1]). The gene discussed is CRP; the disease is ischemic stroke.